R. Berardi

Medical treatment for cholangiocarcinoma

J. Bruix, B. Sangro, J. Valle, 2019, Liver international : official journal of the International Association for the Study of the Liver.

Pre-treatment neutrophil-to-lymphocyte ratio may be associated with the outcome in patients treated with everolimus for metastatic renal cell carcinoma

D. Amadori, R. Berardi, S. Cascinu, 2013, British Journal of Cancer.

Pazopanib and sunitinib trigger autophagic and non-autophagic death of bladder tumour cells

G. Santoni, C. Amantini, R. Berardi, 2013, British Journal of Cancer.

A combination of gefitinib and FOLFOX-4 as first-line treatment in advanced colorectal cancer patients. A GISCAD multicentre phase II study including a biological analysis of EGFR overexpression, amplification and NF-kB activation

R. Labianca, P. Tagliaferri, V. Catalano, 2007, British Journal of Cancer.

High curative resection rate with weekly cisplatin, 5-fluorouracil, epidoxorubicin, 6S-leucovorin, glutathione, and filgastrim in patients with locally advanced, unresectable gastric cancer: a report from the Italian Group for the Study of Digestive Tract Cancer (GISCAD)

S. Barni, R. Labianca, V. Catalano, 2004, British Journal of Cancer.

Supportive oncology and survivorship care: Initial impact of the Coleman Supportive Oncology Collaborative.

F. Penedo, S. Garcia, W. Dale, 2017 .

Promoting patient health maintenance with cancer care planning at diagnosis and during treatment: baseline data of the Coleman Supportive Oncology Collaborative (CSOC).

W. Gradishar, A. Benson, J. Trosman, 2020 .